Postdoc

Dr. Prachi Srivastava is a Postdoctoral Research Associate in the Department of Biomedical Engineering at the New Jersey Institute of Technology (NJIT), USA, with collaborative research experience at Stanford University School of Medicine. Her research focuses on nanomedicine, infectious diseases, antimicrobial resistance, molecular imaging, and translational biomaterials. Dr. Srivastava received her Ph.D. in Bionanotechnology and Biomedical Engineering from the Indian Institute of Technology (BHU), Varanasi, India, where her doctoral research focused on the design and development of alkali earth metal-based nanomaterials for biomedical applications. She also completed an integrated Master of Technology in Biomedical Engineering from the Indian Institute of Information Technology Allahabad and earned a Bachelor of Science degree in Chemistry, Zoology, and Botany from Deen Dayal Upadhyaya Gorakhpur University. Her current research centers on the development of multifunctional nanotherapeutic platforms for the diagnosis and treatment of antimicrobial-resistant infections, chronic wounds, and bacterial biofilms. Her expertise includes antimicrobial nanomaterials, phage therapy, photothermal therapy, nanozymes, bacterial–mammalian co-culture systems, host–pathogen interactions, and multimodal bioimaging. She has extensive experience in photoacoustic imaging, fluorescence imaging, computed tomography, magnetic resonance imaging, and bioluminescence imaging for infectious disease applications. At NJIT, Dr. Srivastava develops antimicrobial nanomaterials and nanotherapeutic platforms for bacterial biofilm eradication and image-guided therapy. Her research includes plasmonic and nanozyme-based systems such as Au@Pt, Au@Pd, Au@Ru, and Au@Ru–CeO₂ nanostructures for antimicrobial and biofilm-related applications. She also works on ultrasound-responsive phage–nanodroplet systems for enhanced biofilm penetration and targeted antimicrobial delivery. During her appointment at Stanford University School of Medicine, she worked on infectious disease nanomedicine approaches for rapid eradication of Gram-negative bacterial infections using phage therapy and plasmonic heating. Her work involved bacterial biofilm assays, wound infection models, bioluminescence imaging, photoacoustic imaging, and evaluation of therapeutic efficacy in preclinical models. She also participated in collaborative projects aimed at developing novel antimicrobial therapies against antibiotic-resistant pathogens. Dr. Srivastava has contributed to the development of metallic magnesium nanoclusters for bioimaging, magnesium-based wound healing gels, Ag₃Mg photothermal nanostructures, fluorescent nanoclusters, and multimodal nanotheranostic systems. Her research interests span antimicrobial resistance, bacterial and fungal biofilms, wound healing, nanozyme platforms, phage therapy, and imaging-guided therapeutics. Her scholarly output includes publications in journals such as Chemical Engineering Science, Colloids and Surfaces B: Biointerfaces, ACS Applied Bio Materials, and JCI Insight, as well as multiple patents related to nanomaterials and wound healing technologies. She has received several awards, including the Women in Molecular Imaging Network (WIMIN) Research Scholar Award and the WMIC Student Travel Stipend Award. Dr. Srivastava has presented her work at numerous international conferences, including the World Molecular Imaging Congress (WMIC), where she delivered an oral presentation on AuPt-based multimodal platforms for antibacterial photothermal therapy and molecular imaging. She actively mentors graduate students, undergraduate researchers, and summer trainees and contributes to scientific outreach, teaching, and interdisciplinary collaborations. Her long-term research vision is to develop clinically translatable nanotheranostic technologies capable of sensing, diagnosing, treating, and monitoring antimicrobial-resistant infections and chronic wounds through integrated imaging and therapeutic approaches.